Hyperfine
Guilford, Connecticut, United States · Biotechnology, Health Care, Health Diagnostics
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) system capable of providing brain imaging at the point of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020 as a bedside magnetic resonance imaging device for producin
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Guilford, Connecticut, United States
- Employees
- 120
- Industries
- Biotechnology, Health Care, Health Diagnostics
- Status
- Public (HYPR)
- Website
- hyperfine.io
- Company page
Recent activity at Hyperfine
- : SEC 8-K (2.02): On October 8, 2026, Hyperfine, Inc. reported preliminary unaudited financial results for the quarter and nine months ended September 30, 2026. The company estimated total revenue of approximately $6.0 million for the quarter and $13.8 million for the nine months. Additionally, as of September 30, 2026, Hyperfine reported estimated cash and cash equivalents of around $37.9 million. These figures are subject to change as they are based on management's preliminary assessments and the completion of their financial processes.
- : SEC 8-K (5.01): On September 17, 2026, Hyperfine, Inc. received a notice from Nasdaq indicating that its Class A common stock has fallen below the minimum bid price of $1.00 for 30 consecutive business days, thus failing to meet the Nasdaq Listing Rule 5450(a)(1). This non-compliance notice does not have immediate implications for the listing or trading of the stock, which continues to trade on Nasdaq under the symbol 'HYPR'. However, it raises concerns regarding the company's compliance and potential strategies it may need to implement to regain compliance and avoid delisting. The situation is significant as it directly impacts investor confidence and could influence future capital raising efforts.
- : Hyperfine, Inc. launched the next generation Swoop® system, a portable MRI, generating strong market demand.
Employee benefit plans
Hyperfine files 1 employee benefit plan with the U.S. Department of Labor. The next plan year renews in Dec 2026.
About Hyperfine: questions and answers
What does Hyperfine do?
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) system capable of providing brain imaging at the point of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020 as a bedside magnetic resonance imaging device for producin
Where is Hyperfine headquartered?
Hyperfine is headquartered in Guilford, Connecticut, United States.
How many employees does Hyperfine have?
Hyperfine has about 120 employees.
What is the latest news on Hyperfine?
On Oct 08, 2026, SEC 8-K (2.02): On October 8, 2026, Hyperfine, Inc. reported preliminary unaudited financial results for the quarter and nine months ended September 30, 2026. The company estimated total revenue of approximately $6.0 million for the quarter and $13.8 million for the nine months. Additionally, as of
Is Hyperfine a public company?
Yes. Hyperfine is publicly traded under the ticker HYPR.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy